GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRNF) » Definitions » Other Operating Expense

Khiron Life Sciences (Khiron Life Sciences) Other Operating Expense : $1.08 Mil (TTM As of Sep. 2022)


View and export this data going back to 2018. Start your Free Trial

What is Khiron Life Sciences Other Operating Expense?

Khiron Life Sciences's Other Operating Expense for the three months ended in Sep. 2022 was $0.25 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2022 was $1.08 Mil.

Khiron Life Sciences's quarterly Other Operating Expense increased from Mar. 2022 ($0.28 Mil) to Jun. 2022 ($0.31 Mil) but then declined from Jun. 2022 ($0.31 Mil) to Sep. 2022 ($0.25 Mil).

Khiron Life Sciences's annual Other Operating Expense increased from Dec. 2019 ($0.28 Mil) to Dec. 2020 ($0.53 Mil) and increased from Dec. 2020 ($0.53 Mil) to Dec. 2021 ($0.75 Mil).


Khiron Life Sciences Other Operating Expense Historical Data

The historical data trend for Khiron Life Sciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Other Operating Expense Chart

Khiron Life Sciences Annual Data
Trend May12 May13 May14 May15 May16 May17 Dec18 Dec19 Dec20 Dec21
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.05 0.28 0.53 0.75

Khiron Life Sciences Quarterly Data
Nov17 Feb18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.23 0.28 0.31 0.25

Khiron Life Sciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Khiron Life Sciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Khiron Life Sciences (Khiron Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5
Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.